Skip to main content
Journal cover image

Effectiveness of Telemedicine Visits in Reducing 30-Day Readmissions Among Patients With Heart Failure During the COVID-19 Pandemic.

Publication ,  Journal Article
Xu, H; Granger, BB; Drake, CD; Peterson, ED; Dupre, ME
Published in: J Am Heart Assoc
April 5, 2022

Background The COVID-19 pandemic resulted in a rapid implementation of telemedicine into clinical practice. This study examined whether early outpatient follow-up via telemedicine is as effective as in-person visits for reducing 30-day readmissions in patients with heart failure. Methods and Results Using electronic health records from a large health system, we included patients with heart failure living in North Carolina (N=6918) who were hospitalized between March 16, 2020 and March 14, 2021. All-cause readmission within 30 days after discharge was examined using weighted logistic regression models. Overall, 7.6% (N=526) of patients received early telemedicine follow-up, 38.8% (N=2681) received early in-person follow-up, and 53.6% (N=3711) did not receive follow-up within 14 days of discharge. Compared with patients without early follow-up, those who received early follow-up were younger, were more likely to be Medicare beneficiaries, had more comorbidities, and were less likely to live in an disadvantaged neighborhood. Relative to in-person visits, those with telemedicine follow-up were of similar age, sex, and race but with generally fewer comorbidities. Overall, the 30-day readmission rate (19.0%) varied among patients who received telemedicine visits (15.0%), in-person visits (14.0%), or no follow-up (23.1%). After covariate adjustment, patients who received either telemedicine (odds ratio [OR], 0.55; 95% CI, 0.44-0.72) or in-person (OR, 0.52; 95% CI, 0.45-0.60) visits were similarly less likely to be readmitted within 30 days compared with patients with no follow-up. Conclusions During the COVID-19 pandemic, the use of telemedicine visits for early follow-up increased rapidly. Patients with heart failure who received outpatient follow-up either via telemedicine or in-person had better outcomes than those who received no follow-up.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

April 5, 2022

Volume

11

Issue

7

Start / End Page

e023935

Location

England

Related Subject Headings

  • United States
  • Telemedicine
  • Patient Readmission
  • Pandemics
  • Medicare
  • Humans
  • Heart Failure
  • COVID-19
  • Aged
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Xu, H., Granger, B. B., Drake, C. D., Peterson, E. D., & Dupre, M. E. (2022). Effectiveness of Telemedicine Visits in Reducing 30-Day Readmissions Among Patients With Heart Failure During the COVID-19 Pandemic. J Am Heart Assoc, 11(7), e023935. https://doi.org/10.1161/JAHA.121.023935
Xu, Hanzhang, Bradi B. Granger, Connor D. Drake, Eric D. Peterson, and Matthew E. Dupre. “Effectiveness of Telemedicine Visits in Reducing 30-Day Readmissions Among Patients With Heart Failure During the COVID-19 Pandemic.J Am Heart Assoc 11, no. 7 (April 5, 2022): e023935. https://doi.org/10.1161/JAHA.121.023935.
Xu H, Granger BB, Drake CD, Peterson ED, Dupre ME. Effectiveness of Telemedicine Visits in Reducing 30-Day Readmissions Among Patients With Heart Failure During the COVID-19 Pandemic. J Am Heart Assoc. 2022 Apr 5;11(7):e023935.
Xu, Hanzhang, et al. “Effectiveness of Telemedicine Visits in Reducing 30-Day Readmissions Among Patients With Heart Failure During the COVID-19 Pandemic.J Am Heart Assoc, vol. 11, no. 7, Apr. 2022, p. e023935. Pubmed, doi:10.1161/JAHA.121.023935.
Xu H, Granger BB, Drake CD, Peterson ED, Dupre ME. Effectiveness of Telemedicine Visits in Reducing 30-Day Readmissions Among Patients With Heart Failure During the COVID-19 Pandemic. J Am Heart Assoc. 2022 Apr 5;11(7):e023935.
Journal cover image

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

April 5, 2022

Volume

11

Issue

7

Start / End Page

e023935

Location

England

Related Subject Headings

  • United States
  • Telemedicine
  • Patient Readmission
  • Pandemics
  • Medicare
  • Humans
  • Heart Failure
  • COVID-19
  • Aged
  • 3201 Cardiovascular medicine and haematology